Trial Profile
Reasons for Dose Reduction of Mycophenolate Mofetil During the First Post-transplant Year in Renal Transplant Recipients and Its Impact on Graft Outcome: a Single-center Retrospective Analysis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 24 Dec 2011 New trial record